Works by Shimizu, Hisashi


Results: 22
    1

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    2
    3

    Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 3, p. 201, doi. 10.1159/000540841
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    4

    Contribution of Soluble Forms of Programmed Death 1 and Programmed Death Ligand 2 to Disease Severity and Progression in Systemic Sclerosis.

    Published in:
    Arthritis & Rheumatology, 2017, v. 69, n. 9, p. 1879, doi. 10.1002/art.40164
    By:
    • Fukasawa, Takemichi;
    • Yoshizaki, Ayumi;
    • Ebata, Satoshi;
    • Nakamura, Kouki;
    • Saigusa, Ryosuke;
    • Miura, Syunsuke;
    • Yamashita, Takashi;
    • Hirabayashi, Megumi;
    • Ichimura, Yohei;
    • Taniguchi, Takashi;
    • Asano, Yoshihide;
    • Shimizu, Hisashi;
    • Kazoe, Yutaka;
    • Mawatari, Kazuma;
    • Kitamori, Takehiko;
    • Sato, Shinichi
    Publication type:
    Article
    5
    6
    7
    8
    9

    ASO Visual Abstract: Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score—A Multicenter Study.

    Published in:
    2024
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Abstract
    10

    Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 13, p. 9023, doi. 10.1245/s10434-024-16161-4
    By:
    • Nakazawa, Nobuhiro;
    • Sohda, Makoto;
    • Hosoi, Nobuhiro;
    • Watanabe, Takayoshi;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Sano, Akihiko;
    • Sakai, Makoto;
    • Ogawa, Hiroomi;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    11
    12
    13

    Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy‐Induced Cytokine Release Syndrome.

    Published in:
    Cancer Reports, 2024, v. 7, n. 7, p. 1, doi. 10.1002/cnr2.2145
    By:
    • Minami, Soichiro;
    • Kawashima, Yosuke;
    • Munakata, Yasuhiko;
    • Matsuno, Masahiro;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    14

    Successful application of lorlatinib in a 23‐year‐old patient with anaplastic lymphoma kinase (ALK)‐positive lung cancer and multiple brain metastases.

    Published in:
    Cancer Reports, 2024, v. 7, n. 2, p. 1, doi. 10.1002/cnr2.1981
    By:
    • Murakami, Yosuke;
    • Kawashima, Yosuke;
    • Chiba, Shinji;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    15

    Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e536, doi. 10.1634/theoncologist.2019-0550
    By:
    • Aso, Mari;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Ogasawara, Takahiro;
    • Tsurumi, Kyoji;
    • Ono, Kana;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    16

    Association of Immune‐Related Adverse Events with Clinical Benefit in Patients with Advanced Non‐Small‐Cell Lung Cancer Treated with Nivolumab.

    Published in:
    Oncologist, 2018, v. 23, n. 11, p. 1358, doi. 10.1634/theoncologist.2017-0384
    By:
    • Toi, Yukihiro;
    • Sugawara, Shunichi;
    • Kawashima, Yosuke;
    • Aiba, Tomoiki;
    • Kawana, Sachiko;
    • Saito, Ryohei;
    • Tsurumi, Kyoji;
    • Suzuki, Kana;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Ono, Hirotaka;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Honda, Yoshihiro
    Publication type:
    Article
    17

    Association of immune‐related pneumonitis with clinical benefit of anti‐programmed cell death‐1 monotherapy in advanced non‐small cell lung cancer.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 14, p. 4796, doi. 10.1002/cam4.4045
    By:
    • Ono, Kana;
    • Ono, Hirotaka;
    • Toi, Yukihiro;
    • Sugisaka, Jun;
    • Aso, Mari;
    • Saito, Ryohei;
    • Kawana, Sachiko;
    • Aiba, Tomoiki;
    • Odaka, Tetsuo;
    • Matsuda, Suguru;
    • Saito, Shin;
    • Narumi, Akane;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Domeki, Yutaka;
    • Terayama, Keisuke;
    • Kawashima, Yosuke;
    • Nakamura, Atsushi;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro
    Publication type:
    Article
    18
    19

    A Patient with an Extra psu dic(15) Chromosome.

    Published in:
    Pediatrics International, 1987, v. 29, n. 5, p. 768, doi. 10.1111/j.1442-200X.1987.tb00376.x
    By:
    • Sakiyama, Takeshi;
    • Noguchi, Yasuyuki;
    • Shimizu, Hisashi;
    • Kitagawa, Teruo;
    • Nakagome, Yasuo
    Publication type:
    Article
    20
    21
    22